These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38771953)

  • 1. Heparanase Stimulation of Physiologic Cardiac Hypertrophy Is Suppressed After Chronic Diabetes, Resulting in Cardiac Remodeling and Dysfunction.
    Lee CS; Shang R; Wang F; Khayambashi P; Wang H; Araujo G; Puri K; Vlodavsky I; Hussein B; Rodrigues B
    Diabetes; 2024 Aug; 73(8):1300-1316. PubMed ID: 38771953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia-induced secretion of endothelial heparanase stimulates a vascular endothelial growth factor autocrine network in cardiomyocytes that promotes recruitment of lipoprotein lipase.
    Zhang D; Wan A; Chiu AP; Wang Y; Wang F; Neumaier K; Lal N; Bround MJ; Johnson JD; Vlodavsky I; Rodrigues B
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2830-8. PubMed ID: 24115032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cell heparanase taken up by cardiomyocytes regulates lipoprotein lipase transfer to the coronary lumen after diabetes.
    Wang Y; Chiu AP; Neumaier K; Wang F; Zhang D; Hussein B; Lal N; Wan A; Liu G; Vlodavsky I; Rodrigues B
    Diabetes; 2014 Aug; 63(8):2643-55. PubMed ID: 24608441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High glucose facilitated endothelial heparanase transfer to the cardiomyocyte modifies its cell death signature.
    Wang F; Jia J; Lal N; Zhang D; Chiu AP; Wan A; Vlodavsky I; Hussein B; Rodrigues B
    Cardiovasc Res; 2016 Dec; 112(3):656-668. PubMed ID: 27979811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling.
    Dugaucquier L; Feyen E; Mateiu L; Bruyns TAM; De Keulenaer GW; Segers VFM
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H443-H455. PubMed ID: 32618511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of VEGFB and its signaling in the diabetic heart is associated with increased cell death signaling.
    Lal N; Chiu AP; Wang F; Zhang D; Jia J; Wan A; Vlodavsky I; Hussein B; Rodrigues B
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1163-H1175. PubMed ID: 28314760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effects of hyperglycemia on endothelial cells and cardiomyocytes to enhance coronary LPL activity.
    Chiu AP; Bierende D; Lal N; Wang F; Wan A; Vlodavsky I; Hussein B; Rodrigues B
    Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H82-H94. PubMed ID: 28986359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation.
    Ryall KA; Bezzerides VJ; Rosenzweig A; Saucerman JJ
    J Mol Cell Cardiol; 2014 Jul; 72():74-84. PubMed ID: 24613264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.
    Huang ZP; Chen J; Seok HY; Zhang Z; Kataoka M; Hu X; Wang DZ
    Circ Res; 2013 Apr; 112(9):1234-43. PubMed ID: 23524588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocyte VEGF Regulates Endothelial Cell GPIHBP1 to Relocate Lipoprotein Lipase to the Coronary Lumen During Diabetes Mellitus.
    Chiu AP; Wan A; Lal N; Zhang D; Wang F; Vlodavsky I; Hussein B; Rodrigues B
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):145-55. PubMed ID: 26586663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propofol ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction via heme oxygenase-1/signal transducer and activator of transcription 3 signaling pathway in rats.
    Xu J; Li H; Irwin MG; Xia ZY; Mao X; Lei S; Wong GT; Hung V; Cheung CW; Fang X; Clanachan AS; Xia Z
    Crit Care Med; 2014 Aug; 42(8):e583-94. PubMed ID: 24810525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MG53, A Novel Regulator of KChIP2 and I
    Liu W; Wang G; Zhang C; Ding W; Cheng W; Luo Y; Wei C; Liu J
    Circulation; 2019 Apr; 139(18):2142-2156. PubMed ID: 30760025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow-Induced Secretion of Endothelial Heparanase Regulates Cardiac Lipoprotein Lipase and Changes Following Diabetes.
    Lee CS; Zhai Y; Shang R; Wong T; Mattison AJ; Cen HH; Johnson JD; Vlodavsky I; Hussein B; Rodrigues B
    J Am Heart Assoc; 2022 Dec; 11(23):e027958. PubMed ID: 36416172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
    Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
    Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Cardiomyocyte α1A-Adrenergic Receptors Attenuates Postinfarct Remodeling by Inducing Angiogenesis Through Heterocellular Signaling.
    Zhao X; Balaji P; Pachon R; Beniamen DM; Vatner DE; Graham RM; Vatner SF
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2451-9. PubMed ID: 26338300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
    Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparanase protects the heart against chemical or ischemia/reperfusion injury.
    Wang F; Pulinilkunnil T; Flibotte S; Nislow C; Vlodavsky I; Hussein B; Rodrigues B
    J Mol Cell Cardiol; 2019 Jun; 131():29-40. PubMed ID: 31004678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.
    Karpanen T; Bry M; Ollila HM; Seppänen-Laakso T; Liimatta E; Leskinen H; Kivelä R; Helkamaa T; Merentie M; Jeltsch M; Paavonen K; Andersson LC; Mervaala E; Hassinen IE; Ylä-Herttuala S; Oresic M; Alitalo K
    Circ Res; 2008 Oct; 103(9):1018-26. PubMed ID: 18757827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.
    Hu MC; Shi M; Cho HJ; Adams-Huet B; Paek J; Hill K; Shelton J; Amaral AP; Faul C; Taniguchi M; Wolf M; Brand M; Takahashi M; Kuro-O M; Hill JA; Moe OW
    J Am Soc Nephrol; 2015 Jun; 26(6):1290-302. PubMed ID: 25326585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
    Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
    Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.